Cargando…
Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention
Ovarian cancer (OC) has gained a great deal of attention due to its aggressive proliferative capabilities, high death rates and poor treatment outcomes, rendering the disease the ultimate lethal gynaecological cancer. Nanotechnology provides a promising avenue to combat this malignancy by the niche...
Autores principales: | Hoosen, Yasar, Pradeep, Priyamvada, Kumar, Pradeep, du Toit, Lisa C., Choonara, Yahya E., Pillay, Viness |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877592/ https://www.ncbi.nlm.nih.gov/pubmed/29510526 http://dx.doi.org/10.3390/ijms19030731 |
Ejemplares similares
-
“On-The-Spot” Arresting of Chondroitin Sulphate Proteoglycans: Implications for Ovarian Adenocarcinoma Recognition and Intervention
por: Pradeep, Priyamvada, et al.
Publicado: (2016) -
Hypothesis: apo‐lactoferrin–Galantamine Proteo‐alkaloid Conjugate for Alzheimer's disease Intervention
por: Akilo, Olufemi D., et al.
Publicado: (2018) -
Synthesis and Properties of CurNQ for the Theranostic Application in Ovarian Cancer Intervention
por: Freidus, Lara G., et al.
Publicado: (2020) -
Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors
por: Frank, Derusha, et al.
Publicado: (2014) -
Chemotherapeutic Efficacy of Implantable Antineoplastic-Treatment Protocols in an Optimal Mouse Model for Human Ovarian Carcinoma Cell Targeting
por: Pantshwa, Jonathan M., et al.
Publicado: (2018)